Which Financial Stock Will Make You Rich: Aviva plc, Banco Santander SA Or Barclays PLC?

Do Aviva plc (LON: AV), Banco Santander SA (LON: BNC) or Barclays PLC (LON: BARC) have the greatest recovery potential? Harvey Jones finds out

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Investors have traditionally wanted plentiful exposure to the financial services sector. It is where the money is, after all. Financials was one of the most rewarding sectors to invest in before the credit crunch and it has been one of the most disastrous ever since. Could it still make you rich?

Life Alive

Banking stocks may have struggled since the financial crisis but the insurance sector has boomed. Over the past five years, Standard Life is up 78%, Asia-focused Prudential has soared 145% and Legal & General Group has flown a joyous 160%. Aviva (LSE: AV), which I bought as a recovery play a few years ago, is up, ahem, 14%. Aviva continues to be the bridesmaid rather than the bride, although looking at those performance figures I wonder whether it has been invited to the wedding at all.

It now looks cheap at around 10 times earnings and even the dividend, cruelly slashed in 2013, is looking respectable again at 3.72%. Maybe Aviva has been harshly treated, given its rapid integration of recent purchase Friends Life, 11 consecutive quarters of new business growth, and progress towards Solvency II capital requirements. Chief executive Mark Wilson’s attempts to build a stronger, leaner business are praiseworthy, although maybe not quite thrilling enough. Forecast earnings per share (EPS) growth of 12% next year, lifting the yield to 5%, suggest that Aviva could make you a little richer. If slowly.

Banco Crisis

Santander (LSE: BNC) has endured a troubled five years seeing its share price has almost halved from 701p to today’s 370p. Only Standard Chartered has fared worse, down 68% over the same period. Both have been punished for the same reason they were celebrated before the financial crisis: their diverse global reach which included plenty of exposure to once booming emerging markets.

In the case of Santander, it is Brazil that has done the damage. The healthier UK economy has compensated, with Santander UK recently reporting a 6% jump in Q3 pre-tax profit to £496m, buoyed by the success of its 123 current account. The European Central Bank’s QE-fuelled attempts to revive the Eurozone may help Santander recover in Spain.

Santander began 2015 by slashing its dividend but it still yields around 3.8%. At 11 times earnings, the price is reasonable. Brazil, however, remains a drag.

BARC Or Bite?

I expected better from Barclays (LSE: BARC) this year but then, I expected better from stock markets generally. The bank is down 16% to 234p over the last three months as investors scorned its Q3 results, which showed adjusted profit before tax down 10% to £1.4bn and a whopping 23% lower than the previous quarter, when it posted £1.85bn.

Investors were also concerned about the prospects for Barclays’ investment banking. A seemingly impressive 31% rise in nine-month profits to £1.76bn apparently fell apart in month 10. Like so many FTSE 100 companies, Barclays is busy cutting costs and ditching non-core assets to focus on UK retail and business banking, Barclaycard and the African businesses. Smaller, leaner Barclays is forecast to grow EPS by 29% this year and 20% next, which looks zippy to me, and the yield is expected to creep up to 3.6%. The recent share price dip makes it a buy but please don’t expect to get rich quick. Then again who does, these days?

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Harvey Jones has no position in any shares mentioned. The Motley Fool UK has recommended Barclays. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »